Subjects: AWD, ASI, DEI
Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year
PALO ALTO, Calif., April 12, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score improved by 7.3 percentage points from 2019 to 2020.
In the annual survey results, Varian ranked first in the following 10 categories: Net Promoter Score; Market Share; Satisfaction; Satisfaction in Grade A Hospitals; Product Quality; Services Quality; Services Attitude; Efficiency; Training; and Parts Delivery Time. These survey results demonstrate Varian's ongoing commitment to its customers through quality products and superior and efficient services.
The 11th annual survey, organized by the China Medical Equipment magazine, collected responses from more than 2,000 hospitals across 32 provinces in the country. It is one of the most influential medical industry performance evaluations conducted in China.
The goal of the survey is to understand and evaluate customer satisfaction with the after-sales service provided by medical technology manufacturers, and to provide those companies with information that can help them standardize and improve the quality of their after-sales service programs.
"Meeting and exceeding our customers' needs is our goal each and every day," said Dr. Zhang Xiao, president of Varian Greater China region. "We are grateful for our customers' recognition, reflected by the results of this survey. It encourages us to pursue excellence and empower our work to deliver technology and innovation in the fight against cancer."
About Varian
At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Aimee Corso
Health + Commerce
+1 (310) 780-2661
[email protected]
Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
[email protected]
SOURCE Varian
These press releases may also interest you
|
News published on and distributed by:
